Navigation Links
Clues to Cancer That Could Wipe Out Tasmanian Devils
Date:12/31/2009

Researchers are working on genetic puzzle to try to save the mammals

THURSDAY, Dec. 31 (HealthDay News) -- Researchers are gaining a better understanding of an outbreak of cancerous tumors that is killing many of Australia's Tasmanian devils, according to a new report.

Devil facial tumor disease, a kind of cancer that's spread from animal to animal through biting or other physical contact, is one of only two types of cancer known to be transmitted in this way through living cancer cells (the other such cancer is in dogs). The disease, which quickly kills the animals, starts out as large tumors on the face and mouth, but then can spread to the animals' internal organs.

Advocates fear that the aggressive tumors could kill off Tasmanian devils within a few decades because there currently is no treatment or vaccine.

"Our findings represent a big step forward in the race to save the devils from extinction," study lead author Elizabeth Murchison, of Cold Spring Harbor Laboratory and the Australian National University, said in a news release from the lab.

The researchers report that they've discovered the genetic basis of the cancer, which appears to be linked to a type of tissue that protects nerve cells.

"Now that we've taken a good look at the tumors' genetic profile, we can start hunting for genes and pathways involved in tumor formation," study co-author Greg Hannon, also of Cold Spring Harbor Laboratory, stated in the news release.

The findings are published in the Jan. 1 issue of the journal Science.

More information

The San Diego Zoo has facts about Tasmanian devils.



-- Randy Dotinga



SOURCE: Cold Spring Harbor Laboratory, news release, Dec. 31, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Twins Provide Clues to Lupus
2. Researchers find clues to why some continue to eat when full
3. Smell of old books offers clues to help preserve them
4. Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis
5. Research Yields Clues to Severe Form of Sinusitis
6. Facial Structure May Hold Clues to Aggression
7. Gene Discovery Gives Clues to Crohns Disease, Colitis
8. New Clues to How Fish Oils Help Arthritis Patients
9. Clues to visual variant Alzheimers; myopia and diabetic retinopathy risk
10. Clues to Hypertension in Kids May Be Seen in Bones
11. Brain Yields Up Clues to Language
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/17/2017)... ... August 17, 2017 , ... When Amy Cowperthwait left ... she took with her a dream to make nursing education more relevant and prepare ... communication skills were integrated into healthcare provider education. , “The human element ...
(Date:8/17/2017)... ... August 17, 2017 , ... The line-up includes voices from all ... grow a dental practice in a competitive market environment where Corporate Dentistry is making ... just transform you and your practice.” says Daniel A. ‘Danny’ Bobrow, AIM Dental Marketing’s ...
(Date:8/17/2017)... ... August 17, 2017 , ... ... distinguishes herself once more by being among Houston’s first plastic surgeons to offer ... quality plastic surgery care without disrupting busy schedules and maintaining the utmost discretion ...
(Date:8/17/2017)... ... 17, 2017 , ... Florida Hospital Zephyrhills showcased its newly ... The newly renovated ER was designed with patients in mind and offers: 24 ... to deliver patient results, improve efficiencies and reduce length of stay, two pirate-themed ...
(Date:8/17/2017)... ... , ... With the introduction of new devices, new features, and updates to ... smartwatch market. As of June 2017, nearly nine percent of U.S. consumers aged 18+ ... according to latest WEAR Report Industry Overview and Forecast from NPD’s Connected Intelligence, growth ...
Breaking Medicine News(10 mins):
(Date:8/8/2017)... -- BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical company focused ... for the second quarter ended June 30, 2017. ... and to date: ... Company,s lead project, BL-8040: Announced plans ... novel stem cell mobilization treatment for autologous bone-marrow transplantation ...
(Date:8/7/2017)... Diplomat Pharmacy, Inc. (NYSE: DPLO ) today announced ... Aug. 7, 2017. ... and will serve as president emeritus during a planned, 90-day ... multiple leadership roles since he joined Diplomat with the acquisition ... decisive, strategic leadership which continues to benefit our patients and ...
(Date:8/4/2017)... , Aug. 3, 2017  Agragen, LLC, a ... active in the biopharmaceutical, nutraceutical, and aquacultural feed ... of its lead drug candidates, AGR131.  This drug ... cytokine from the blood of patients suffering from ... inflammatory bowel disease. ...
Breaking Medicine Technology: